Piramal Critical Care launches new Zinc Sulfate concentration in US to expand injectable portfolio
Piramal Critical Care (PCC), a division of Piramal Pharma Limited, has announced the introduction of a new concentration of Zinc Sulfate for Injection USP in the U.S. market. This 10mg/10mL (1 mg/mL) concentration is a strategic addition to PCC’s existing Zinc Sulfate Injection product line and overall generic injectables portfolio. Addressing Pediatric Nutritional Needs with […]